Hemostasis Today

No Clear Benefit of Short-Term Dual Antiplatelet Therapy in TIA or Stroke Without ≥50% Stenosis – International Journal of Stroke
Jul 31, 2026, 16:37

No Clear Benefit of Short-Term Dual Antiplatelet Therapy in TIA or Stroke Without ≥50% Stenosis – International Journal of Stroke

International Journal of Stroke shared a post on LinkedIn about a recent article by Mateus Kist Ibiapino et al., adding:

”New meta-analysis

In patients with TIA or ischemic stroke without at least 50 percent large-artery stenosis, the benefit of short-term dual antiplatelet therapy is uncertain and may come with a higher bleeding risk.”

Title: Dual Antiplatelet Therapy in Stroke Without Stenotic Atherosclerosis: A Meta-Analysis with Trial Sequential Analysis

Authors: Mateus Kist Ibiapino, Marwa Ibrahim, Vanisha Kumar, Diana Lissie Mamani-Sucari, Sofia Zuppi Sardinha Mantovani, Igor Haitovich, Leonardo Caetano Borgomanero, Gisele Sampaio Silva

No Clear Benefit of Short-Term Dual Antiplatelet Therapy in TIA or Stroke Without ≥50% Stenosis - International Journal of Stroke

Stay updated on all scientific advances with Hemostasis Today.